![](/img/cover-not-exists.png)
PMH30 COST-EFFECTIVENESS ANALYSIS IN THE AUSTRALIAN SETTING OF RISPERIDONE LONG-ACTING INJECTION FOR THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA WHO ARE PARTIALLY ADHERENT TO THEIR MEDICATION
S Crowley, R Schrover, AM NevilleVolume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)66089-5
File:
PDF, 82 KB
english, 2004